"Sulfinpyrazone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Descriptor ID |
D013442
|
| MeSH Number(s) |
D03.383.129.539.850.777.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sulfinpyrazone".
Below are MeSH descriptors whose meaning is more specific than "Sulfinpyrazone".
This graph shows the total number of publications written about "Sulfinpyrazone" by people in this website by year, and whether "Sulfinpyrazone" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Sulfinpyrazone" by people in Profiles.
-
Cooper DR, Kelliher GJ, Kowey PR. Modulation of arachidonic acid metabolites and vulnerability to ventricular fibrillation during myocardial ischemia in the cat. Am Heart J. 1988 Nov; 116(5 Pt 1):1194-200.
-
Hanson SR, Harker LA, Bjornsson TD. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. J Clin Invest. 1985 May; 75(5):1591-9.
-
Mahony C, Wolfram KM, Nash PV, Bjornsson TD. Kinetics and metabolism of sulfinpyrazone. Clin Pharmacol Ther. 1983 Apr; 33(4):491-7.
-
Rogers PH, Walsh PN, Marder VJ, Bosak GC, Lachman JW, Ritchie WG, Oppenheimer L, Sherry S. Controlled trial of low-dose heparin and sulfinpyrazone to prevent venous thromboembolism after operation on the hip. J Bone Joint Surg Am. 1978 Sep; 60(6):758-62.